Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:21 pm Purchase | 13G | ATHIRA PHARMA INC ATHA | BAKER BROS. ADVISORS LP | 3,153,807 8.3% | 3,153,807 (New Position) | View |
| 2023-12-29 5:15 pm Purchase | 13D | ATHIRA PHARMA INC ATHA | PERCEPTIVE ADVISORS LLC | 5,458,448 14.3% | 647,299 (+13.45%) | View |
| 2023-07-07 4:35 pm Sale | 13G | ATHIRA PHARMA INC ATHA | BlackRock Inc. BLK | 669,768 1.8% | -1,693,453 (-71.66%) | View |
| 2023-04-20 5:27 pm Purchase | 13G | ATHIRA PHARMA INC ATHA | KAYNE RICHARD A | 1,983,668 5.3% | 1,983,668 (New Position) | View |
| 2023-02-14 10:27 am Sale | 13G | ATHIRA PHARMA INC ATHA | RTW INVESTMENTS LP | 0 0% | -1,906,557 (Position Closed) | View |
| 2023-02-01 4:54 pm Sale | 13G | ATHIRA PHARMA INC ATHA | BlackRock Inc. BLK | 2,363,221 6.2% | -92,463 (-3.77%) | View |
| 2023-01-30 1:38 pm Sale | 13G | ATHIRA PHARMA INC ATHA | FRANKLIN RESOURCES INC BEN | 0 0% | -2,080,050 (Position Closed) | View |
| 2022-07-01 4:45 pm Purchase | 13D | ATHIRA PHARMA INC ATHA | PERCEPTIVE ADVISORS LLC | 4,811,149 12.8% | 1,385,233 (+40.43%) | View |
| 2022-02-14 5:02 pm Sale | 13G | ATHIRA PHARMA INC ATHA | VIKING GLOBAL INVESTORS LP | 0 0% | -2,120,653 (Position Closed) | View |
| 2022-02-14 4:14 pm Sale | 13G | ATHIRA PHARMA INC ATHA | Venrock Healthcare Capital Partners II L.P. | 1,000,000 2.7% | -691,623 (-40.89%) | View |
| 2022-02-14 08:09 am Sale | 13G | ATHIRA PHARMA INC ATHA | RTW INVESTMENTS LP | 1,906,557 5.1% | -779,222 (-29.01%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | ATHIRA PHARMA INC ATHA | BlackRock Inc. BLK | 2,455,684 6.6% | 2,455,684 (New Position) | View |
| 2022-02-03 11:55 am Purchase | 13G | ATHIRA PHARMA INC ATHA | FRANKLIN RESOURCES INC BEN | 2,080,050 5.6% | 2,080,050 (New Position) | View |
| 2021-02-16 4:06 pm Purchase | 13G | ATHIRA PHARMA INC ATHA | Venrock Healthcare Capital Partners II L.P. | 1,691,623 5.2% | 34,000 (+2.05%) | View |
| 2021-02-16 06:03 am Purchase | 13G | ATHIRA PHARMA INC ATHA | KAWAS LEEN | 1,693,102 5.2% | 1,693,102 (New Position) | View |
| 2021-02-12 7:55 pm Unchanged | 13G | ATHIRA PHARMA INC ATHA | VIKING GLOBAL INVESTORS LP | 2,120,653 6% | 0 (Unchanged) | View |
| 2021-02-12 09:31 am Purchase | 13G | ATHIRA PHARMA INC ATHA | RTW INVESTMENTS LP | 2,685,779 8.26% | 16,866 (+0.63%) | View |
| 2021-02-08 5:16 pm Purchase | 13D | ATHIRA PHARMA INC ATHA | PERCEPTIVE ADVISORS LLC | 3,425,916 9.8% | 3,425,916 (New Position) | View |
| 2020-11-16 4:05 pm Purchase | 13G | ATHIRA PHARMA INC ATHA | Venrock Healthcare Capital Partners II L.P. | 1,657,623 5.1% | 1,657,623 (New Position) | View |
| 2020-09-28 5:04 pm Purchase | 13G | ATHIRA PHARMA INC ATHA | VIKING GLOBAL INVESTORS LP | 2,120,653 6.9% | 2,120,653 (New Position) | View |